L47 - glecaprevir/pibrentasvir - maviret - derivado del a. marco 27/2022 de medicamentos exclusivos del sermas - hcd
Procedimiento Abierto de Inspeccion General de Sanidad de la Defensa. . Adjudicado el 16-09-2024.Inspección General de Sanidad de la Defensa. Ministerio de Defensa.
Last update: 13/02/2025
Contract details:
Object of the contract
L47 - glecaprevir/pibrentasvir - maviret - derivado del a. marco 27/2022 de medicamentos exclusivos del sermas - hcd.
File number
633/2024
Processing Type
Ordinaria
Procedure of contracting
Abierto
Contracting system for its celebration
No aplica
Type of agreement
Suministros
Organ of contracting
Inspección General de Sanidad de la Defensa.
Contracting body type:
Inspeccion General de Sanidad de la Defensa.
Tender details:
State
Ajudicada (ADJ)
Amount of bidding
15.384,62€
Number of bidders
1
Number of offers received from SMEs
0
Outcome of the tender
Adjudicado
Awardee details:
Awardee
ABBVIE SPAIN, S.L.. ( NIF: B86418787 )
The beneficiary is an SME?
No
Amount of adjudication
15,384.62€
For more information:
More information on this contract in the Platform for Recruitment of the Public Sector